Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Hypoxia and free radicals, such as reactive oxygen and nitrogen species, can alter the function and/or activity of the transcription factor hypoxia-inducible factor 1 (HIF1). Interplay between free radicals, hypoxia and HIF1 activity is complex and can influence the earliest stages of tumour development. The hypoxic environment of tumours is heterogeneous, both spatially and temporally, and can change in response to cytotoxic therapy. Free radicals created by hypoxia, hypoxia-reoxygenation cycling and immune cell infiltration after cytotoxic therapy strongly influence HIF1 activity. HIF1 can then promote endothelial and tumour cell survival. As discussed here, a constant theme emerges: inhibition of HIF1 activity will have therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many human cancers contain regions of hypoxia because of rapid cell proliferation and the presence of intratumoral blood vessels that are structurally and functionally abnormal, resulting in both spatial and temporal heterogeneity of blood flow (1, 2).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS production later stabilizes the HIF-1α protein and increases expression of HIF-1α and its target genes (Moeller et al., 2004;Dewhirst et al., 2008;Harada et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dewhirst et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedPlum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“The HIF1α subunit is exquisitely regulated by hydroxylation of proline residues in its oxygen-dependent degradation domain (ODD) that target it for recognition by the von Hippel Lindau (VHL) complex and subsequent proteasomal degradation under aerobic condition”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“Origins of hypoxia in solid tumours The presence of hypoxia in tumours is a well-established source of resistance to radiation therapy and chemotherap”
Background
Cited by
Items 401–500 of 999
Das, B. C., Madhukumar, A. V., Anguiano, J., & Mani, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.110 · Cited by 40
Gordon, R. R., Wu, M., Huang, C.-Y., Harris, W. P., Sim, H. G., Lucas, J. M., Coleman, I. M., Higano, C. S., Gulati, R., True, L. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104271 · Cited by 39
Barajas, R., Pampaloni, M. H., Clarke, J. L., Seo, Y., Savic, D., Hawkins, R. A., Behr, S. C., Chang, S. M., Berger, M. S., Dillon, W. P., et al. (2015) · Case Reports in Radiology · doi:10.1155/2015/731361 · Cited by 38
Nakamura, T., Yamashita, K., Sato, T., Ema, A., Naito, M., & Watanabe, M. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.03.007 · Cited by 40
Oxygen-dependent regulation of immune checkpoint mechanisms
Ohta, A. (2018) · International Immunology · doi:10.1093/intimm/dxy038 · Cited by 39
Sattiraju, A., & Mintz, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-16908-4_2 · Cited by 41
Hypoxia differently modulates the release of mitochondrial and nuclear DNA
Otandault, A., Abraham, J.-D., Dache, Z. A. A., Khalyfa, A., Jariel‐Encontre, I., Forné, T., Prévostel, C., Chouaïb, S., Gozal, D., & Thierry, A. R. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0716-y · Cited by 44
Lopes‐Coelho, F., Martins, F., Hipólito, A., Mendes, C., Sequeira, C. O., Pires, R. F., Almeida, A. M., Bonifácio, V. D. B., Pereira, S. A., & Serpa, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.656229 · Cited by 42
Guan, Z., Lan, H., Cai, X., Zhang, Y., Liang, A., & Li, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722917 · Cited by 44
Arai, M., Kawachi, T., Setiawan, A., & Kobayashi, M. (2010) · ChemMedChem · doi:10.1002/cmdc.201000302 · Cited by 38
Imaging the Impact of Nox4 in Cycling Hypoxia-mediated U87 Glioblastoma Invasion and Infiltration
Hsieh, C., Chang, H., Shen, W., Shyu, W., & Liu, R.-S. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0516-0 · Cited by 37
Effects of High-Dose Microbeam Irradiation on Tumor Microvascular Function and Angiogenesis
Fontanella, A. N., Boss, M., Hadsell, M., Zhang, J., Schroeder, T., Berman, K., Dewhirst, M. W., Chang, S., & Palmer, G. M. (2015) · Radiation Research · doi:10.1667/rr13712.1 · Cited by 42
Self-citationWelter, M., Fredrich, T., Rinneberg, H. H., & Rieger, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161267 · Cited by 44
Personalized fMRI Delineates Functional Regions Preserved within Brain Tumors
Cui, W., Wang, Y., Ren, J., Hubbard, C. S., Fu, X., Fang, S., Wang, D., Zhang, H., Li, Y., Li, L., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26303 · Cited by 37
Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer
Sharma, R., & Malviya, R. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188869 · Cited by 37
Spatio-Temporal Dynamics of Hypoxia during Radiotherapy
Kempf, H., Bleicher, M., & Meyer‐Hermann, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133357 · Cited by 46
The Role of Hypoxia Regulated microRNAs in Cancer
McCormick, R., Buffa, F. M., Ragoussis, J., & Harris, A. L. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_76 · Cited by 39
Cheng, Y.-C., Liou, J., Kuo, C., Lai, W.-Y., Shih, K.-H., Chang, C.-Y., Pan, W., Tseng, J. T.-C., & Chang, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0778 · Cited by 39
Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2α, which Is Relevant during Hypoxia
Blaustein, M., Pérez-Munizaga, D., Sánchez, M. A., Urrutia, C., Grande, A., Risso, G., Srebrow, A., Alfaro, J., & Colman‐Lerner, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069668 · Cited by 38
Arai, M., Kawachi, T., Sato, H., Setiawan, A., & Kobayashi, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.116 · Cited by 38
Zhu, H., Yang, X., Ding, Y., Liu, J., Lü, J., Zhan, L., Qin, Q., Zhang, H., Chen, X., Yang, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep14503 · Cited by 38
ATM activation in hypoxia - causes and consequences
Olcina, M. M., Grand, R. J. A., & Hammond, E. M. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29903 · Cited by 41
Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma
Soares, A. B., de Araújo, V. C., Juliano, P. B., & Altemani, A. (2009) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2009.00794.x · Cited by 35
Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis
Martial, S. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00218.2015 · Cited by 40
Chang, E. T., Parekh, P. R., Yang, Q., Nguyen, D. M., & Carrier, F. (2016) · Oncotarget · doi:10.18632/oncotarget.7020 · Cited by 37
Overcoming Radioresistance: Small Molecule Radiosensitisers and Hypoxia-activated Prodrugs
Jackson, R. K., Liew, L. P., & Hay, M. P. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.004 · Cited by 39
Gouardères, S., Mingotaud, A., Vicendo, P., & Gibot, L. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1814735 · Cited by 37
Bioactive metal-containing nanomaterials for ferroptotic cancer therapy
Fei, W., Zhang, Y., Ye, Y., Li, C., Yao, Y., Zhang, M., Li, F., & Zheng, C. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02138e · Cited by 36
Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution
Romero, Y., & Aquino‐Gálvez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158335 · Cited by 41
Yuan, M., Zhai, Y., Men, Y., Zhao, M., Sun, X., Ma, Z., Bao, Y., Yang, X., Sun, S., Liu, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5479491 · Cited by 36
“…antiangiogenic therapy can improve both radiotherapy and immunotherapy by downregulating the level of angiogenic factors, normalizing blood vessels, alleviating hypoxia, adjusting cell cycle, balancing the tumor microenvironment, and eliminating immunosuppressive factors to some degree [14 – 16].”
Metz, S., Ganter, C., Lorenzen, S., van Marwick, S., Holzapfel, K., Herrmann, K., Rummeny, E. J., Wester, H., Schwaiger, M., Nekolla, S. G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132386 · Cited by 36
Béjot, R., Kersemans, V., Kelly, M., Carroll, L. S., King, R. C., Gouverneur, V., Elizarov, A. M., Ball, C., Zhang, J., Miraghaie, R., et al. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.03.011 · Cited by 34
Lee, H. Y., Lee, H. J., Kim, Y. T., Kang, C. H., Jang, B. G., Chung, D. H., Goo, J. M., Park, C. M., Lee, C. H., & Kang, K. W. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d2efe7 · Cited by 35
Transcriptome Remodeling in Hypoxic Inflammation
Safronova, O. S., & Morita, I. (2010) · Journal of Dental Research · doi:10.1177/0022034510366813 · Cited by 40
AKT as locus of cancer multidrug resistance and fragility
Radisavljevic, Z. M. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24176 · Cited by 34
Use of the ODD-Luciferase Transgene for the Non-Invasive Imaging of Spontaneous Tumors in Mice
Goldman, S. J., Chen, E., Taylor, R., Zhang, S., Petrosky, W., Reiß, M., & Jin, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018269 · Cited by 43
Science to Practice: What Does MR Oxygenation Imaging Tell Us about Human Breast Cancer Hypoxia?
Padhani, A. R. (2009) · Radiology · doi:10.1148/radiol.091669 · Cited by 34
Angiogenesis: a phenomenon which aggravates chronic liver disease progression
Kukla, M. (2012) · Hepatology International · doi:10.1007/s12072-012-9391-2 · Cited by 37
Isotopologous Organotellurium Probes Reveal Dynamic Hypoxia In Vivo with Cellular Resolution
Edgar, L. J., Vellanki, R. N., McKee, T. D., Hedley, D. W., Wouters, B. G., & Nitz, M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201607483 · Cited by 37
Al-Asmari, A. K., Riyasdeen, A., & Islam, M. (2018) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2156587217751796 · Cited by 39
Suo, M., Liu, Z., Tang, W., Guo, J., Jiang, W., Liu, Y., & Duo, Y. (2020) · Nanoscale · doi:10.1039/d0nr06594c · Cited by 36
Sanduleanu, S., Jochems, A., Upadhaya, T., Even, A. J. G., Leijenaar, R. T. H., Dankers, F. J. W. M., Klaassen, R., Woodruff, H. C., Hatt, M., Kaanders, H., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.10.016 · Cited by 35
Quarta, A., Gaballo, A., Pradhan, B., Patra, S., Jena, M., & Ragusa, A. (2021) · Applied Sciences · doi:10.3390/app112211041 · Cited by 36
The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia
Gallez, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853568 · Cited by 37
Koizume, S., & Miyagi, Y. (2015) · Cancers · doi:10.3390/cancers8010002 · Cited by 40
Thézénas, M., Leo, B. D., Laux‐Biehlmann, A., Bafligil, C., Elger, B., Tapmeier, T. T., Morten, K., Rahmioğlu, N., Dakin, S. G., Charles, P. D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58362-3 · Cited by 43
Macklin, P. S., Yamamoto, A., Browning, L., Hofer, M., Adam, J., & Pugh, C. W. (2020) · The Journal of Pathology · doi:10.1002/path.5402 · Cited by 35
Heterogeneity of Glucose Transport in Lung Cancer
Martinez, C. A., & Scafoglio, C. (2020) · Biomolecules · doi:10.3390/biom10060868 · Cited by 40
Mechanisms of resistance to ionizing radiation in rectal cancer
Huerta, S., Gao, X., & Saha, D. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.26 · Cited by 37
Wuthrick, E. J., Kamrava, M. R., Curran, W. J., Werner‐Wasik, M., Camphausen, K. A., Hyslop, T., Axelrod, R. S., Andrews, D. W., Glass, J., Machtay, M. X., et al. (2011) · Cancer · doi:10.1002/cncr.26216 · Cited by 34
Regulation of tumor angiogenesis by the crosstalk between innate immunity and endothelial cells
Ebeling, S., Kowalczyk, A., Pérez-Vázquez, D., & Mattiola, I. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1171794 · Cited by 39
The correlation between NEDD4L and HIF-1α levels as a gastric cancer prognostic marker
Jiang, X., Zhang, S., Yin, Z., Sheng, Y., Yan, Q., Sun, R., Lu, M., Zhang, Z., & Li, Y. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.34646 · Cited by 33
Zou, R., Gong, Q., Shi, Z., Zheng, J., Xing, J., Chuang, L. I. U., Jiang, Z., & Wu, A. (2020) · Nanoscale · doi:10.1039/d0nr02580a · Cited by 31
Replication catastrophe induced by cyclic hypoxia leads to increased APOBEC3B activity
Bader, S. B., Ma, T. S., Simpson, C. J., Liang, J., Maezono, S. E. B., Olcina, M. M., Buffa, F. M., & Hammond, E. M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab551 · Cited by 34
Hypoxic Jumbo Spheroids On-A-Chip (HOnAChip): Insights into Treatment Efficacy
Refet-Mollof, E., Najyb, O., Chermat, R., Glory, A., Lafontaine, J., Wong, P., & Gervais, T. (2021) · Cancers · doi:10.3390/cancers13164046 · Cited by 36
Hypoxia modulates the effect of dihydroartemisinin on endothelial cells
D’Alessandro, S., Basilico, N., Corbett, Y., Scaccabarozzi, D., Omodeo‐Salè, F., Saresella, M., Marventano, I., Vaillant, M., Olliaro, P., & Taramelli, D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.002 · Cited by 33
Laser flow cytometry as a tool for the advancement of clinical medicine
Aebisher, D., Bartusik‐Aebisher, D., & Tabarkiewicz, J. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.048 · Cited by 35
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia
Saliakoura, M., Sebastiano, M. R., Pozzato, C., Heidel, F. H., Schnoeder, T. M., Prince, S. S., Bubendorf, L., Pinton, P., Schmid, R. A., Baumgartner, J., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00592-8 · Cited by 34
Cao, H., Wang, L., Yang, Y., Li, J., Qi, Y., Li, Y., Li, Y., Wang, H., & Li, J. (2018) · Angewandte Chemie · doi:10.1002/ange.201802497 · Cited by 31
Sheng, J., Wu, J., Yin, X., Sun, Z., Wang, X., Zhang, J., Tang, J., Ji, Y., Song, J., Wei, X., et al. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.08.018 · Cited by 32
Martínez‐Romero, R., Cañuelo, A., Siles, E., Oliver, F. J., & Martínez‐Lara, E. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00898.2011 · Cited by 33
Jia, J.-B., Wang, W., Sun, H., Liu, L., Zhu, X., Kong, L., Chai, Z., Zhang, W., Zhang, J., Xu, H., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9435-1 · Cited by 31
Honokiol inhibits hypoxia-inducible factor-1 pathway
Lan, K.-L., Lan, K., Sheu, M., Chen, M., Shih, Y.-S., Hsu, F.-C., Wang, H.-M., Liu, R.-S., & Yen, S.-H. (2011) · International Journal of Radiation Biology · doi:10.3109/09553002.2011.568572 · Cited by 34
Redler, G., Epel, B., & Halpern, H. J. (2013) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24631 · Cited by 31
Demasi, A. P. D., Costa, A. F., Altemani, A., Furuse, C., de Araújo, N. S., & de Araújo, V. C. (2010) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00702.x · Cited by 35
Totti, S., Vernardis, S. I., Meira, L. B., Pérez-Mancera, P. A., Costello, E., Greenhalf, W., Palmer, D. H., Neoptolemos, J. P., Mantalaris, A., & Velliou, E. G. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.012 · Cited by 34
Functional Imaging of Hypoxia: PET and MRI
Perez, R. C., Kim, D., Maxwell, A. W. P., & Camacho, J. C. (2023) · Cancers · doi:10.3390/cancers15133336 · Cited by 38
Xie, D., Yan, X., Shang, W., Ren, H., Wen, W., Tang, B. Z., & Su, H. (2025) · ACS Nano · doi:10.1021/acsnano.5c00942 · Cited by 37
Meng, M., Jiang, X., Deng, L., Na, F., He, J., Xue, J., Guo, W., Wen, Q., Lan, J., Mo, X., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.10.022 · Cited by 30
Chen, R.-Q., Yang, Q., Chen, Y., Oliveira, V. A., Dalton, W. S., Fearns, C., & Lee, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014316 · Cited by 33
Nakajima, E. C., Laymon, C. M., Oborski, M. J., Hou, W., Wang, L., Grandis, J. R., Ferris, R. L., Mountz, J. M., & Houten, B. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102452 · Cited by 34
Lee, J., Ryu, Y., Ji, Y., Kang, J. H., & Moon, E. (2015) · Oncotarget · doi:10.18632/oncotarget.3218 · Cited by 30
Resistance to angiogenesis inhibitors in renal cell carcinoma.
Tamaskar, I., Dhillon, J., & Пили, Р. (2011) · PubMed · Cited by 33
miRNA networks modulate human endothelial cell adaptation to cyclic hypoxia
Kochan-Jamrozy, K., Króliczewski, J., Moszyńska, A., Collawn, J. F., & Bartoszewski, R. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2018.11.020 · Cited by 30
Hypoxia increases mutational load of breast cancer cells through frameshift mutations
Venkatesh, G. H., Bravo, P. E., El‐Sayed, W., Francis, A., Wojtaś, B., Khouzam, R. A., Nawafleh, H. H., Mallya, S. P., Satyamoorthy, K., Dessen, P., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1750750 · Cited by 34
McNabb, E., Al‐Mahrouki, A., Law, N., McKay, S., Tarapacki, C. M., Hussein, F., & Czarnota, G. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239456 · Cited by 30
Villarreal‐García, V., Estupiñan‐Jiménez, J. R., Vivas‐Mejía, P. E., González-Villasana, V., Vázquez-Guillén, J. M., & Reséndez‐Pérez, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.980694 · Cited by 36
Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy
Dong, Q., Xue, T., Yan, H., Liu, F., Liu, R., Zhang, K., Chong, Y., Du, J., & Zhang, H. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02152-2 · Cited by 33
“The previous studies have shown that the tumor oxygenation strategy cannot effectively inhibit the expression of HIF-1α, which induces tumor resistance to radiation [55].”
BackgroundWuthrick, E. J., Curran, W. J., Camphausen, K. A., Lin, A., Glass, J., Evans, J. J., Andrews, D. W., Axelrod, R. A., Shi, W., Werner‐Wasik, M., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.05.034 · Cited by 30
Keir, S. T., Dewhirst, M. W., Kirkpatrick, J. P., Bigner, D. D., & Batinic̈‐Haberle, I. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011795255957 · Cited by 33
Self-citationTravelling under pressure - hypoxia and shear stress in the metastatic journey
Ildız, E. S., Gvozdenovic, A., Kovacs, W. J., & Aceto, N. (2023) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10224-8 · Cited by 39
Aprile, G., Ongaro, E., Re, M. D., Lutrino, S. E., Bonotto, M., Ferrari, L., Rihawi, K., Cardellino, G. G., Pella, N., Danesi, R., et al. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.02.009 · Cited by 30
Cell cycle progression in glioblastoma cells is unaffected by pathophysiological levels of hypoxia
Richards, R., Jenkinson, M. D., Haylock, B. J., & Sée, V. (2016) · PeerJ · doi:10.7717/peerj.1755 · Cited by 32
Both Full-Length and Protease-Cleaved Products of Osteopontin Are Elevated in Infectious Diseases
Hattori, T., Iwasaki, H., Bai, G., Yasutan, H. C., Shete, A., Telan, E. F. O., Takahashi, A., Ashino, Y., & Matsuba, T. (2021) · Biomedicines · doi:10.3390/biomedicines9081006 · Cited by 31
Wang, A., Fang, J. Y., Ye, S., Mao, Q., Zhao, Y., Cui, C., Zhang, Y., Feng, Y., Li, J., He, L., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c21062 · Cited by 31
Reactive Oxygen Species are Essential for Placental Angiogenesis During Early Gestation
Yang, Y., Jin, H., Qiu, Y., Liu, Y., Li, W., Fu, Y., Qi, H., Baker, P. N., & Tong, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4290922 · Cited by 36
“Inaddition, ROS-induced oxidative stress initiates the secretion of angiogenic modulators, such as VEGF and HIF-1 α [42 – 44], which have been shown to promote the growth of fetoplacental vessels.”
Mitochondria in cancer: clean windmills or stressed tinkerers?
Altieri, D. C. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.08.001 · Cited by 32
Proposal of a hybrid approach for tumor progression and tumor-induced angiogenesis
Cumsille, P., Coronel, A., Conca, C., Quiñinao, C., & Escudero, C. (2015) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-015-0009-y · Cited by 28
Gao, X., Wei, S., Lai, K., Sheng, J., Su, J., Zhu, J., Dong, H., Hu, H., & Xu, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144477 · Cited by 33
Sasidharan, A., Sivaram, A. J., Retnakumari, A. P., Chandran, P., Malarvizhi, G. L., Nair, S. V., & Koyakutty, M. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201400670 · Cited by 29
The circadian clock and hypoxia in tumor cell de-differentiation and metastasis
Jensen, L. D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.025 · Cited by 29
Zhao, Y., Shen, L., Chen, X., Qian, Y., Zhou, Q., Wang, Y. X., Li, K., Liu, M., Zhang, S., & Huang, X. (2015) · PubMed · doi:10.14670/hh-11-627 · Cited by 31
Hsieh, C., Kuo, J.-W., Lee, Y., Chang, C., Gelovani, J. G., & Liu, R.-S. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.061234 · Cited by 30
Garbuzenko, D. V., Arefyev, N. O., & Belov, D. V. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i16.665 · Cited by 30
The Influence of Exercise on Cancer Risk, the Tumor Microenvironment and the Treatment of Cancer
He, A., Pu, Y., Jia, C., Wu, M., He, H., & Xia, Y. (2024) · Sports Medicine · doi:10.1007/s40279-024-02031-2 · Cited by 38
“Abnormalities in tumor vascular structure and function can result in intratumor hypoxia and insufficient blood supply [132].”
MIER2/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma
Wei, Z., Ye, Y., Liu, C., Wang, Q., Zhang, Y., Chen, K., Cheng, G., & Zhang, X. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.032 · Cited by 31
“…vascular progenitor cells and pro-angiogenic monocytes to maintain the continuity of tumor neovascularization in a VEGF-independent manner [11]; 3) Increase the coverage of endothelial cells in the vascular bed around the tumor, maintain the stability of the new blood vessel structure,…”
Nonthermal-plasma-mediated animal cell death
Kim, W., Woo, K., Kim, G., & Kim, K. (2010) · Journal of Physics D Applied Physics · doi:10.1088/0022-3727/44/1/013001 · Cited by 34
Integrated Proteomic and Metabolic Analysis of Breast Cancer Progression
Shaw, P. G., Chaerkady, R., Wang, T., Vasilatos, S. N., Huang, Y., Houten, B. V., Pandey, A., & Davidson, N. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076220 · Cited by 35
Mass Spectrometry Analyses of Multicellular Tumor Spheroids
Acland, M., Mittal, P., Lokman, N. A., Klingler‐Hoffmann, M., Oehler, M. K., & Hoffmann, P. (2018) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700124 · Cited by 38
“Moreover, hypoxia in the central layers of MCTS has been shown to reduce the effectiveness of radiation and chemotherapy [22, 23] as well as being a factor which promotes metastasis and progression [24, 25].”
BackgroundRatai, E., Zhang, Z., Fink, J. R., Muzi, M., Hanna, L., Greco, E. M., Richards, T. L., Kim, D., Andronesi, O. C., Mintz, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198548 · Cited by 32
“One of the pathologic hallmarks of GBM is tumor hypoxia resulting from an inefficient blood supply [2].”
Metadata
- Authors
- Dewhirst, M. W., Cao, Y., & Moeller, B.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Dewhirst, Mark W.
- Venue
- Nature Reviews Cancer
- Published
- 2008-06
- Volume
- 8
- Issue
- 6
- Pages
- 425-437
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3943205
- OpenAlex
- W2016861891
- Cited by
- 1,022
- References
- 161
- Citations by year
- 2026: 27 · 2025: 29 · 2024: 30 · 2023: 52 · 2022: 60 · 2021: 70 · 2020: 76 · 2019: 44 · 2018: 64 · 2017: 53 · 2016: 73 · 2015: 65 · 2014: 63 · 2013: 63 · 2012: 62
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-07-03)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA40355, R01CA040355, P50CA068438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- tumor hypoxia, free radicals, reactive oxygen species, reactive nitrogen species, HIF-1, tumor angiogenesis, radiotherapy response, tumor heterogeneity, immune cell infiltration, tumor cell survival, endothelial cells
- MeSH terms
- Animals, Free Radicals, Humans, Neoplasms, Neovascularization, Pathologic, Nitric Oxide, Oxygen, Cell Hypoxia, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.